Therapeutic applications of compounds in the Magnolia family
Top Cited Papers
- 31 May 2011
- journal article
- review article
- Published by Elsevier BV in Pharmacology & Therapeutics
- Vol. 130 (2), 157-176
- https://doi.org/10.1016/j.pharmthera.2011.01.010
Abstract
No abstract availableKeywords
This publication has 99 references indexed in Scilit:
- Magnesium for treatment-resistant depression: A review and hypothesisMedical Hypotheses, 2010
- Anti-inflammatory effect of 4-O-methylhonokiol, a novel compound isolated from Magnolia officinalis through inhibition of NF-κBChemico-Biological Interactions, 2009
- Liquiritin potentiate neurite outgrowth induced by nerve growth factor in PC12 cellsCytotechnology, 2009
- Recent advances in our understanding of neurodegenerationJournal of Neural Transmission, 2009
- Protective effect of the ethanol extract of Magnolia officinalis and 4-O-methylhonokiol on scopolamine-induced memory impairment and the inhibition of acetylcholinesterase activityJournal of Natural Medicines, 2009
- Effects of honokiol and magnolol on acute and inflammatory pain models in miceLife Sciences, 2007
- Synthesis, cytotoxicity, and antiviral activities of new neolignans related to honokiol and magnololBioorganic & Medicinal Chemistry Letters, 2007
- Rapid recovery from major depression using magnesium treatmentMedical Hypotheses, 2006
- Protective effects of honokiol against oxidized LDL-induced cytotoxicity and adhesion molecule expression in endothelial cellsChemico-Biological Interactions, 2006
- Resveratrol Inhibits AGEs-Induced Proliferation and Collagen Synthesis Activity in Vascular Smooth Muscle Cells from Stroke-Prone Spontaneously Hypertensive RatsBiochemical and Biophysical Research Communications, 2000